Anika Therapeutics (ANIK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,880 | -11,172 | -8,843 | -4,873 | -56,385 |
| Depreciation Amortization | 5,729 | 4,411 | 3,008 | 1,592 | 10,583 |
| Income taxes - deferred | -7 | 18 | 15 | 18 | 260 |
| Accounts receivable | 408 | 1,953 | 659 | 3,034 | 3,366 |
| Accounts payable and accrued liabilities | 42 | -835 | -1,066 | 47 | -2,506 |
| Other Working Capital | -823 | 308 | -4,102 | -269 | -13,092 |
| Other Operating Activity | 16,719 | 11,868 | 10,010 | 321 | 63,177 |
| Operating Cash Flow | $11,188 | $6,551 | $-319 | $-130 | $5,403 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 1,329 | 483 | 328 | N/A | N/A |
| PPE Investments | -6,226 | -5,578 | -3,691 | -2,824 | -7,734 |
| Net Acquisitions | 4,496 | 4,496 | 4,496 | 4,496 | -600 |
| Investing Cash Flow | $-401 | $-599 | $1,133 | $1,672 | $-8,334 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | N/A | N/A | 76 |
| Common Stock Repurchased | -9,485 | -3,971 | -3,971 | -3,971 | -10,914 |
| Other Financing Activity | -1,066 | -1,301 | -1,288 | -1,467 | -1,891 |
| Financing Cash Flow | $-10,551 | $-5,272 | $-5,259 | $-5,438 | $-12,729 |
| Exchange Rate Effect | 86 | 151 | 453 | 108 | -48 |
| Beginning Cash Position | 57,159 | 57,159 | 57,159 | 57,159 | 72,867 |
| End Cash Position | 57,481 | 57,990 | 53,167 | 53,371 | 57,159 |
| Net Cash Flow | $322 | $831 | $-3,992 | $-3,788 | $-15,708 |
| Free Cash Flow | |||||
| Operating Cash Flow | 11,188 | 6,551 | -319 | -130 | 5,403 |
| Capital Expenditure | -6,826 | -6,178 | -4,291 | -2,824 | -7,734 |
| Free Cash Flow | 4,362 | 373 | -4,610 | -2,954 | -2,331 |